Clinical Trials PDF Print E-mail

Here is a listing of company and investigator-sponsored (IST) clinical trials with their corresponding details.


We welcome the opportunity to work with clinical researchers who share our excitement in studying bavituximab, a first- in-class PS-targeting antibody currently in multiple oncology clinical trials.

Click here to download an IST application.

NSCLC: Non-Small Cell Lung Cancer
IST: Investigator-Sponsored Trial